Amanote Research

Amanote Research

  • Register
  • Sign In

Novel Anti-Melanoma Immunotherapies: Disarming Tumor Escape Mechanisms

Clinical and Developmental Immunology

doi 10.1155/2012/818214

Full Text

Abstract

Available in

Date

January 1, 2012

Authors

Sivan SapoznikOhad HammerRona OrtenbergMichal J. BesserTehila Ben-MosheJacob SchachterGal Markel

Publisher

Hindawi Limited


Related search

Metastatic Tumor Dormancy in Cutaneous Melanoma: Does Surgery Induce Escape?

Cancers
Cancer ResearchOncology
2011English

Novel Immunotherapies in Lymphoid Malignancies

Nature Reviews Clinical Oncology
Oncology
2015English

Novel Immunotherapies for Autoimmune Hepatitis

Frontiers in Pediatrics
Child HealthPediatricsPerinatology
2017English

A Novel Anti-Melanoma SRC-family Kinase Inhibitor

Oncotarget
Oncology
2019English

Beta-Endorphin - Novel Anti-Tumor Activity

Madridge Journal of Oncogenesis
2019English

Novel Cancer Immunotherapies and Antitumor Immunity

Journal of Immunology Research
MedicineAllergyImmunology
2019English

1201 Melanoma Cell-Intrinsic TNFAIP3 Promotes Tumor Progression and Immune Escape by Activating STAT3

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2018English

Modulation of the Tumor Microenvironment and Inhibition of EGF/EGFR Pathway: Novel Anti-Tumor Mechanisms of Cannabidiol in Breast Cancer

Molecular Oncology
Cancer ResearchMedicineOncologyGeneticsMolecular Medicine
2015English

Golimumab: A Novel Anti-Tumor Necrosis Factor

Biologics in Therapy
2013English

Amanote Research

Note-taking for researchers

Follow Amanote


© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy